Brammer Bio Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 600

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Brammer Bio General Information

Description

Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides clinical and commercial development, manufacturing supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with the process and analytical development, and regulatory support, enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.

Contact Information

Website
www.brammerbio.com
Formerly Known As
Florida Biologix
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 250 Binney Street
  • Cambridge, MA 02142
  • United States
+1 (866)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Thermo Fisher Scientific
Vertical(s)
Life Sciences
Corporate Office
  • 250 Binney Street
  • Cambridge, MA 02142
  • United States
+1 (866)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brammer Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Brammer Bio‘s full profile, request access.

Request a free trial

Brammer Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of viral vector for gene and cell therapies, intended to improve patients' health. The company provides cli
Biotechnology
Cambridge, MA
600 As of 2019

Beijing, China
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Brammer Bio Competitors (54)

One of Brammer Bio’s 54 competitors is BeiGene, a Formerly PE-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BeiGene Formerly PE-Backed Beijing, China
Parexel International Private Equity-Backed Durham, NC
Lonza Group Corporation Basel, Switzerland
CordenPharma Private Equity-Backed Plankstadt, Germany
FinVector Private Debt Financed Kuopio, Finland
You’re viewing 5 of 54 competitors. Get the full list »

Brammer Bio Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Brammer Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4425446-A1 Supervised machine learning based classification of adeno associated viruses in cryogenic electron microscopy (cryo-em) Pending 01-Mar-2023
JP-2024147497-A Supervised machine learning based on classification of adeno associated viruses in cryogenic electron microscopy (cryo-em) Pending 01-Mar-2023
US-20240428602-A1 Supervised machine learning based classification of adeno associated viruses in cryogenic electron microscopy (cryo-em) Pending 01-Mar-2023
EP-4540375-A1 Improved recombinant adeno-associated virus production Pending 20-Jun-2022
EP-4493699-A1 Lentiviral manufacturing platform Pending 14-Mar-2022 C12N15/86
To view Brammer Bio’s complete patent history, request access »

Brammer Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brammer Bio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Brammer Bio‘s full profile, request access.

Request a free trial

Brammer Bio Investments (1)

Brammer Bio’s most recent deal was a Buyout/LBO with Brammer Biopharmaceuticals. The deal was made on 31-Mar-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Brammer Biopharmaceuticals 31-Mar-2016 Buyout/LBO Biotechnology
To view Brammer Bio’s complete investments history, request access »

Brammer Bio FAQs

  • When was Brammer Bio founded?

    Brammer Bio was founded in 2006.

  • Where is Brammer Bio headquartered?

    Brammer Bio is headquartered in Cambridge, MA.

  • What is the size of Brammer Bio?

    Brammer Bio has 600 total employees.

  • What industry is Brammer Bio in?

    Brammer Bio’s primary industry is Biotechnology.

  • Is Brammer Bio a private or public company?

    Brammer Bio is a Private company.

  • What is the current valuation of Brammer Bio?

    The current valuation of Brammer Bio is .

  • What is Brammer Bio’s current revenue?

    The current revenue for Brammer Bio is .

  • Who are Brammer Bio’s investors?

    Ampersand (Massachusetts) and University of Florida Investment Corporation have invested in Brammer Bio.

  • Who are Brammer Bio’s competitors?

    BeiGene, Parexel International, Lonza Group, CordenPharma, and FinVector are some of the 54 competitors of Brammer Bio.

  • When was Brammer Bio acquired?

    Brammer Bio was acquired on 30-Apr-2019.

  • Who acquired Brammer Bio?

    Brammer Bio was acquired by Thermo Fisher Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »